肘管减压术 资料
本指南由基兰·希尔帕拉（Kieran Hirpara）医生在罗克汉普顿 Mater 私人医院为您提供肘部尺神经松解术（鹰嘴窝松解术）后的康复指导。它说明了您应预期的情况、前几周需要注意的事项，以及在恢复期间保持神经自由滑动的练习。请将此页面或其 PDF 文件带给您的物理治疗师或手部治疗师，以确保您的康复计划协调一致。您的治疗师可能会根据您的恢复进展调整该计划。
如果您在术后对伤口有任何担忧，请联系诊所。拍摄伤口的照片并通过电子邮件发送以供审查通常很有帮助。
两种不同的手术，两种略有不同的恢复过程。 尺神经主要有两种松解方式，您接受的手术类型会影响您早期的注意事项：
- 原位（简单）减压： 神经在其原有位置被松解，不发生移位。这是希尔帕拉医生常规执行的手术，恢复迅速：早期即可进行轻柔的肘关节全范围活动。不使用硬质支具。
- 前（肌下）移位（将神经提起并重新路由至肘部前方更受保护的位置）：仅在较少见的情况下进行，即当肘关节弯曲时，神经在骨性突起（内上髁）上方发生半脱位或脱位。这需要更谨慎的早期阶段，在前几周避免肘关节屈曲和伸展至终末范围，以便神经和软组织在新位置稳定下来。可仅佩戴简单吊带以提供舒适感。
请根据您接受的手术类型遵循以下指导：大多数情况下为原位手术，神经不稳定时进行移位手术。
预期情况
关于伤口、肿胀和疤痕的管理，请参阅本诊所的伤口护理指南。
手术的目的是减轻尺神经（负责小指和无名指感觉并支配手部许多小肌肉的神经）的压力。一旦压力解除，神经开始恢复，但神经愈合缓慢。
症状改善的速度很大程度上取决于神经受压的时间长短以及术前神经受刺激的严重程度。刺痛和麻木感通常会首先缓解，有时在几天或几周内即可改善。麻木感和手部力量的恢复则需要更长时间（通常需要数月），且最终结果可能在术后一年或更长时间内持续改善。如果术前神经长期受到严重刺激，部分麻木或无力可能无法完全恢复；此时手术旨在阻止病情恶化，并为神经恢复提供最佳机会。
对比两种手术方式，对已发表试验的大型综述发现，单纯原位减压和前移位术的总体结果相似，其中单纯减压术的伤口和软组织并发症相对较少[1][2]。选择哪种手术方式由您的外科医生根据您的神经和肘部情况决定。
注意事项与限制
从治疗初期开始，鼓励在舒适范围内进行手部日常功能的轻度使用，如自我护理、进食、穿衣、书写和打字。
早期的活动限制取决于您接受的手术类型：
- 原位（简单）减压术后（常规手术）： 鼓励早期进行轻柔的肘部、前臂、手腕和手部全范围活动，以促进神经滑动。不使用支具。在最初约六周内，保持提举、抓握及手臂承重为轻度，之后逐渐增加。
- 前移术后（仅当您的神经不稳定时）： 肘部在最初几周内受到保护；避免强行完全屈曲或完全伸直，并避免长时间保持屈曲位，以便神经在新的位置稳定下来。可仅佩戴简单吊带以提供舒适感。神经滑动练习开始的时间晚于简单松解术（通常在术后两至三周）。与原位松解术一样，在最初约六周内保持提举和抗阻训练为轻度，之后逐渐增加。
作为一般指导原则，提举和抗阻强化训练在术后约六周内保持轻度，之后逐渐增加 [3][4]。
倚靠肘部（将肘部 resting 在坚硬表面上）会对神经产生直接压力，在神经恢复期间应避免此动作。
伤口愈合后，疤痕按摩有助于保持神经上方皮肤和组织的柔韧性。有关疤痕管理的更多信息，请参阅 伤口护理 页面。
这些是您手册中的练习，请按照每张卡片上的描述进行操作。请在 Hirpara 医生和治疗师的指导下开始练习：神经滑动练习的开始日期以及任何肘部活动范围限制，取决于您接受的手术类型。
您的练习
重返工作与活动
大多数人可在1至2周内恢复办公室工作或轻度工作，而较重的、重复性或体力劳动通常需约4至8周。当伤口能够耐受特定任务所涉及的接触和压力，且您能在上述注意事项下舒适地完成该任务时，即表明您已准备好进行该项任务。如果您的工作较重、涉及肘部支撑，或使用振动工具，请在术后复查时提出，以便制定计划（包括任何调整后的职责）。
驾驶通常在2至3周后恢复，前提是已不再使用吊带，且能在无痛情况下控制车辆并在紧急情况下做出反应。重返运动和 overhead 活动通常在6至12周左右。
神经恢复遵循其自身较慢的时间线。麻木感通常最先缓解，在数天至数周内出现，而感觉减退和肌力则会在数月内持续改善，并可能持续好转长达约1年。若神经曾长时间严重受压，部分感觉减退或肌力减弱可能无法完全恢复，此时手术的目标则是阻止病情进一步进展。
术后方案
本方案与诊所的一般康复建议配合使用：请参阅术后疼痛管理、伤口护理和手部治疗基础。上述分阶段计划与关于肘部尺神经减压的已发表证据一致，您的后续康复将由您的物理治疗师或手部治疗师根据您的神经和肘部恢复情况进行个体化指导。
参考文献
[1] Said J, Van Nest D, Foltz C, 等. 特发性肘管综合征的尺神经原位减压与移位术：更新后的荟萃分析. J Hand Microsurg. 2019;11(1):18–27. https://pmc.ncbi.nlm.nih.gov/articles/PMC6431285/ [2] Macadam SA, Gandhi R, Bezuhly M, Lefaivre KA. 单纯减压与尺神经前皮下及肌下移位治疗肘管综合征：一项荟萃分析. J Hand Surg Am. 2008;33(8):1314.e1–12. https://pubmed.ncbi.nlm.nih.gov/18929194/ [3] Caliandro P, La Torre G, Padua R, Giannini F, Padua L. 肘部尺神经病变的治疗. Cochrane Database Syst Rev. 2016;11:CD006839. https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD006839.pub4/full [4] Andrews K, Rowland A, Pranjal A, Ebraheim N. 肘管综合征：解剖、临床表现及管理. J Orthop. 2018;15(3):832–836. https://pmc.ncbi.nlm.nih.gov/articles/PMC6082832/
Evidence & references
This is the clinical evidence summary written for health professionals. It is technical, and it lists the research this page was built from. You do not need to read it to understand your treatment or to make a decision about it.
Topic scope: post-operative rehabilitation after surgical decompression of the ulnar nerve at the elbow. The single defining branch point is the operative technique: (A) in-situ (simple) decompression — an early-full-motion pathway; versus (B) anterior transposition (subcutaneous or submuscular) — a protected early phase that avoids end-range elbow flexion/extension for the first few weeks to protect the transposed nerve and its soft-tissue bed.
Defining principle of the rehab here: decompression relieves pressure on a nerve; it does not, by itself, create a load-bearing repair that needs months of protection. So the rehab is fundamentally an early-motion, nerve-glide pathway aimed at preventing perineural adhesion while the nerve recovers on its own (slow) biological timeline. The one variable that changes the early phase is whether the nerve was transposed — a transposed nerve sits in a new bed and end-range elbow excursion is restricted briefly to protect it, so nerve glides start later and elbow ROM is capped for a few weeks. Phase timings below are typical of published surgeon protocols and institutional consensus rather than trial-derived.
A. PROCEDURE CHOICE & OUTCOME EQUIVALENCE
- In-situ decompression and anterior transposition give equivalent clinical outcomes. Multiple meta-analyses of RCTs and comparative series find no significant difference in motor nerve conduction velocity or clinical outcome scores between simple decompression and transposition for idiopathic cubital tunnel syndrome. Strong (multiple SR/meta-analyses).
- Simple decompression carries a lower complication burden (wound, soft-tissue, devascularisation risk), and is often preferred where the nerve is stable and does not subluxate. Moderate–strong.
- Transposition is selected for nerve instability/subluxation, prior failed in-situ release, bony deformity, or a hostile cubital tunnel floor — surgeon's intra-operative judgement. Consensus.
- Endoscopic vs open in-situ decompression show comparable outcomes; choice does not change the rehab pathway (both early-motion). Moderate (SR).
B. POST-OPERATIVE REHABILITATION
Common principles (both pathways)
- Early digital, wrist and shoulder motion from day 1 to prevent stiffness and oedema.
- Ulnar nerve gliding to prevent perineural adhesion — timing differs by pathway (see below).
- No elbow leaning / direct pressure over the nerve during recovery.
- Wound: suture removal ~10–14 days; scar massage and desensitisation once healed.
- Nerve recovery is slow and graded: paraesthesia often improves first (days–weeks); numbness and intrinsic strength lag (months); final outcome continues to ~12 months. DASH, clinical findings and NCV improve postoperatively, with significant early gains by ~1 month in cohort data. Pre-operative severity/chronicity is the dominant predictor of incomplete recovery.
Phased timeline (typical of published surgeon protocols)
| Phase | In-situ (simple) decompression | Anterior transposition (SC / submuscular) |
|---|---|---|
| Week 0–2 | Soft dressing; early active full elbow ROM + digit/wrist/shoulder ROM; light ADLs | Splint/sling for comfort/protection (often elbow ~semi-flexed early); avoid end-range flexion AND extension, and avoid sustained/prolonged elbow flexion; digit/wrist/shoulder ROM |
| Week 2–6 | Progress to full unrestricted active ROM; scar massage + desensitisation once healed; nerve glides as tolerated | Suture out ~10–14d; gradually restore elbow ROM within set limits; scar/desensitisation; introduce nerve glides — typically deferred to this window |
| Week ~6+ | Strengthening / lifting built up as tolerated; return to full activity | Restrictions usually lifted ~6 wk; resistance strengthening from ~6 wk; build up gradually |
Dr Hirpara's practice parameters:
- Default operation = in-situ (simple) decompression; anterior submuscular transposition is reserved for a nerve that subluxates over the medial epicondyle. No rigid brace is used.
- Early elbow ROM: full active elbow motion from day 1 after in-situ decompression. After a transposition the elbow is protected from end-range flexion/extension for the first few weeks (a simple sling for comfort only — no rigid brace).
- Nerve glides: start early/as-tolerated after in-situ; start around 2–3 weeks after a transposition.
- Lifting: kept light (around ≤2 kg) for the first ~6 weeks, then resistance strengthening is built up gradually.
- Nerve recovery: paraesthesia settles first (days–weeks); numbness and intrinsic strength recover over months and can keep improving to ~12 months. Pre-operative severity/chronicity is the dominant predictor — long-standing severe compression may not fully recover, and surgery then aims to halt progression.
C. KEY CONTROVERSIES / EVIDENCE QUALITY
- Procedure equivalence is well supported (multiple meta-analyses); the complication-profile advantage of simple decompression drives the "in-situ first unless unstable" stance. Strong.
- The post-op rehab protocol itself is consensus/expert — drawn from surgeon patient-guidance protocols, not a rehab RCT. Phase timings are typical, not trial-derived. Weak/consensus.
- Nerve-glide evidence is stronger as a non-operative and adhesion-prevention measure than as a proven post-operative outcome-changer; biomechanical and clinical work supports gliding to reduce excursion-related symptoms. Moderate.
D. EVIDENCE STRENGTH FLAGS (summary)
- STRONG (SR / meta-analysis): clinical-outcome equivalence of in-situ decompression vs anterior transposition; lower complication rate with simple decompression.
- MODERATE (cohorts / SR): endoscopic vs open in-situ equivalence; post-op DASH/NCV improvement with early gains by ~1 month; nerve-gliding rationale.
- WEAK / CONSENSUS: the post-operative rehabilitation protocol (surgeon patient-guidance documents; no defining rehab RCT) — including the transposition early-ROM cap, nerve-glide start date, and the ~6-week lifting/strengthening threshold.
CITATIONS
RAG corpus (180,000+ Orthopaedic articles)
- Open vs retractor-endoscopic in-situ decompression of the ulnar nerve in cubital tunnel syndrome. Neurosurgery. DOI: 10.1227/neu.0b013e3182846dbd
- Randomized, prospective study comparing ulnar neurolysis in situ with submuscular transposition. Neurosurgery. DOI: 10.1227/01.neu.0000194847.04143.a1
- Open versus endoscopic in situ decompression in cubital tunnel syndrome: a systematic review. Int J Surg. 2016. DOI: 10.1016/j.ijsu.2016.09.012
- Simple decompression vs. subcutaneous anterior transposition of the ulnar nerve (2025). J Hand Surg Glob Online / XRRT. DOI: 10.1016/j.xrrt.2025.100630
- Cubital tunnel syndrome: current concepts. Curr Rev Musculoskelet Med. 2020. DOI: 10.1007/s12178-020-09650-y
- Predictors of surgical revision after in situ decompression of the ulnar nerve. J Shoulder Elbow Surg. 2015. DOI: 10.1016/j.jse.2014.12.015
- Clinical outcomes of ulnar nerve gliding exercise in the nonoperative treatment of cubital tunnel syndrome. JSES Int. 2025. DOI: 10.1016/j.jseint.2025.02.001
- Biomechanical analysis of ulnar nerve gliding and elongation. Clin Shoulder Elbow. 2024. DOI: 10.5397/cise.2024.00934
- Postoperative improvement in DASH score, clinical findings and nerve conduction velocity in cubital tunnel syndrome. Sci Rep. 2016. DOI: 10.1038/srep27497
Comparative-effectiveness literature (URLs)
- Said J, et al. Ulnar nerve in situ decompression versus transposition for idiopathic cubital tunnel syndrome: an updated meta-analysis. J Hand Microsurg. 2019. https://pmc.ncbi.nlm.nih.gov/articles/PMC6431285/
- Macadam SA, et al. Simple decompression versus anterior subcutaneous and submuscular transposition of the ulnar nerve: a meta-analysis. J Hand Surg Am. 2008. https://pubmed.ncbi.nlm.nih.gov/18929194/
- Caliandro P, et al. Treatment for ulnar neuropathy at the elbow. Cochrane Database Syst Rev. 2016;CD006839. https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD006839.pub4/full
- Andrews K, et al. Cubital tunnel syndrome: anatomy, clinical presentation, and management. J Orthop. 2018. https://pmc.ncbi.nlm.nih.gov/articles/PMC6082832/
Published rehab protocols (patient-guidance — basis for the phase structure)
- University of Virginia Orthopaedics — Cubital Tunnel Release, In-situ Rehabilitation Guidelines. https://med.virginia.edu/orthopaedic-surgery/wp-content/uploads/sites/242/2024/09/Cubital-tunnel-release-in-situ.pdf
- University of Virginia Orthopaedics — Cubital Tunnel Release, Anterior Subcutaneous Transposition. https://med.virginia.edu/orthopaedic-surgery/wp-content/uploads/sites/242/2024/09/Cubital-tunnel-release-anterior-subcutaneous-transposition.pdf
- AAOS OrthoInfo — Cubital Tunnel Release (patient recovery expectations). https://orthoinfo.aaos.org/en/treatment/cubital-tunnel-release/
